ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

Efficacy and Safety of Evinacumab in Adult Patients With Severe Hypertriglyceridemia for the Prevention of Recurrent Acute Pancreatitis

ClinicalTrials.gov ID: NCT04863014

Public ClinicalTrials.gov record NCT04863014. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 18, 2026, 1:13 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Evinacumab in Patients With Severe Hypertriglyceridemia for the Prevention of Recurrent Acute Pancreatitis

Study identification

NCT ID
NCT04863014
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Regeneron Pharmaceuticals
Industry
Enrollment
21 participants

Conditions and interventions

Interventions

  • Placebo Other
  • evinacumab Drug

Other · Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 11, 2021
Primary completion
Feb 14, 2023
Completion
Feb 14, 2023
Last update posted
May 21, 2024

2021 – 2023

United States locations

U.S. sites
32
U.S. states
20
U.S. cities
29
Facility City State ZIP Site status
Radin Cardivascular Medical Group, Inc Newport Beach California 92663
Yale Cancer Center - Yale University New Haven Connecticut 06510
Excel Medical Clinical Trials, LLC Boca Raton Florida 33434
Harmony Medical Research Institute, Inc. Hialeah Florida 33015
Northeast Georgia Medical Center Gainesville Georgia 30501
NorthShore Medical Group Evanston Illinois 60201
Advocate Medical Group Midwest Heart Specialists Park Ridge Illinois 60068
Methodist Medical Center of Illiniois - UnityPoint Clinic Peoria Illinois 61636
Quincy Medical Group Quincy Illinois 62301
St. Vincent Medical Group, Inc. Carmel Indiana 46290
University of Kansas Medical Center Kansas City Kansas 66160
Johns Hopkins University School of Medicine Baltimore Maryland 21287
Minneapolis Heart Institute Minneapolis Minnesota 55407
University of Minnesota Minneapolis Minnesota 55422
Saint Louis University St Louis Missouri 63110
Washington University School of Medicine St Louis Missouri 63110
Northwell Health Manhasset New York 11030
NYU Langone Hospital - Long Island Mineola New York 11501
Weill Cornell Medical College New York New York 10021
Mt Sinai - Ichan Medical Institute New York New York 10029
Wake Forest University Health Sciences Winston-Salem North Carolina 27157
University of Cincinnati Hospital Cincinnati Ohio 45267
Penn Medicine: University of Pennsylvania Health System Philadelphia Pennsylvania 19104
University Of Pittsburgh Pittsburgh Pennsylvania 15213
Medical University of South Carolina Charleston South Carolina 29425
University Diabetes & Endocrine Consultants Chattanooga Tennessee 37411
Methodist Dallas Medical Center Dallas Texas 75208
Sante Clinical Research Kerrville Texas 78028
University of Washington Seattle Washington 98109
MultiCare Institute for Research Spokane Washington 99202
West Virginia University Heart & Vascular Institute Morgantown West Virginia 26506
Wisconsin Center for Advanced Research - a division of GI Associates, LLC Milwaukee Wisconsin 53215

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04863014, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 21, 2024 · Synced May 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04863014 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →